Detalhe da pesquisa
1.
Acquired Resistance to Clinical Cancer Therapy: A Twist in Physiological Signaling.
Physiol Rev
; 96(3): 805-29, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27142452
2.
Complication rates of peripherally inserted central catheters vs implanted ports in patients receiving systemic anticancer therapy: A retrospective cohort study.
Int J Cancer
; 153(7): 1397-1405, 2023 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37254629
3.
[Long-term side effects of immune checkpoint inhibition].
Ther Umsch
; 80(8): 367-372, 2023 Oct.
Artigo
em Alemão
| MEDLINE | ID: mdl-37971528
4.
[Strategies for Shared Decision-making in Therapy for Patients with Oncological Disease - Quo vadis?] / Strategien zur gemeinsamen Entscheidungsfindung in der Therapie bei Patient_innen mit onkologischen Erkrankungen.
Ther Umsch
; 79(8): 401-408, 2022.
Artigo
em Alemão
| MEDLINE | ID: mdl-36164740
5.
Reliability of liquid biopsy analysis: an inter-laboratory comparison of circulating tumor DNA extraction and sequencing with different platforms.
Lab Invest
; 100(11): 1475-1484, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32616816
6.
Inhibition of Akt and other AGC kinases: A target for clinical cancer therapy?
Semin Cancer Biol
; 48: 70-77, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28473255
7.
Inflammatory Cytokines Induce Podoplanin Expression at the Tumor Invasive Front.
Am J Pathol
; 188(5): 1276-1288, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29458011
8.
Trametinib after disease reactivation under dabrafenib in Erdheim-Chester disease with both BRAF and KRAS mutations.
Blood
; 129(7): 879-882, 2017 02 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-27940476
9.
SwissMTB: establishing comprehensive molecular cancer diagnostics in Swiss clinics.
BMC Med Inform Decis Mak
; 18(1): 89, 2018 10 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-30373609
10.
[Neoadjuvant, adjuvant and palliative systemic therapy of colorectal cancer]. / Neoadjuvante, adjuvante und palliative onkologische Therapie beim kolorektalen Karzinom.
Ther Umsch
; 75(10): 622-626, 2018.
Artigo
em Alemão
| MEDLINE | ID: mdl-31232658
11.
SAKK 24/09: safety and tolerability of bevacizumab plus paclitaxel vs. bevacizumab plus metronomic cyclophosphamide and capecitabine as first-line therapy in patients with HER2-negative advanced stage breast cancer - a multicenter, randomized phase III trial.
BMC Cancer
; 16(1): 780, 2016 10 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27724870
12.
Vemurafenib-induced radiation recall dermatitis: case report and review of the literature.
Dermatology
; 230(1): 1-4, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25472806
13.
Tumor invasion in the absence of epithelial-mesenchymal transition: podoplanin-mediated remodeling of the actin cytoskeleton.
Cancer Cell
; 9(4): 261-72, 2006 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-16616332
14.
Olaparib not cost-effective as maintenance therapy for platinum-sensitive, BRCA1/2 germline-mutated metastatic pancreatic cancer.
PLoS One
; 19(4): e0301271, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38573891
15.
A Phase I Study of the Oral Dual-Acting Pan-PI3K/mTOR Inhibitor Bimiralisib in Patients with Advanced Solid Tumors.
Cancers (Basel)
; 16(6)2024 Mar 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38539472
16.
Tolerability, safety, pharmacokinetics, and efficacy of doxorubicin-loaded anti-EGFR immunoliposomes in advanced solid tumours: a phase 1 dose-escalation study.
Lancet Oncol
; 13(12): 1234-41, 2012 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-23153506
17.
Biology, vulnerabilities and clinical applications of circulating tumour cells.
Nat Rev Cancer
; 23(2): 95-111, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36494603
18.
Pre-treatment comorbidities, C-reactive protein and eosinophil count, and immune-related adverse events as predictors of survival with checkpoint inhibition for multiple tumour entities.
Cancer Med
; 12(11): 12253-12262, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37084178
19.
Recognition of and treatment recommendations for oligometastatic disease in multidisciplinary tumor boards.
Clin Transl Radiat Oncol
; 38: 123-129, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36420098
20.
A multicenter phase II trial of anti-EGFR-immunoliposomes loaded with doxorubicin in patients with advanced triple negative breast cancer.
Sci Rep
; 13(1): 3705, 2023 03 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36879012